A.D.A.M. Innovations Co., Japan's leading genomics and AI company, has officially launched GeneLink, a revolutionary advertising platform that merges genetic data, lifestyle insights, and artificial intelligence to pioneer precision marketing, shifting from demographic targeting to biological personalization built on the nation's largest genomic database.
GeneLink marks a transformative advancement in ad-tech, transcending traditional demographic and behavioral methods by incorporating biological predispositions for deeper, more relevant consumer connections. Leveraging A.D.A.M. Innovations' extensive genomic resources, the platform enables brands to deliver tailored campaigns that resonate on a personal level, fostering trust and driving measurable outcomes. This innovation positions GeneLink as a compelling alternative in the ad-tech space, emphasizing ethical data use and value creation for all stakeholders. With over 2.8 million genetic tests conducted, A.D.A.M. Innovations draws from unparalleled Japanese population data to ensure precision unmatched by conventional platforms.
At its core, GeneLink harnesses AI to analyze genetic, metabolic, and wellness factors, allowing marketers to craft campaigns aligned with individual health predispositions and lifestyle patterns. Tools include DNA-informed product sampling for targeted trials, in-app promotional experiences, look-alike audience modeling, and bespoke genomic segmentation for refined targeting. This approach not only enhances campaign effectiveness but also promotes wellness by linking advertising to preventive health recommendations. Brands gain access to sophisticated analytics that optimize reach and ROI, while the platform's shared-economy model incentivizes user participation through rewards.
“With GeneLink, we are not just transforming advertising, we are redefining how brands and individuals connect,” said Michel Mommejat, President of A.D.A.M. Innovations. “By combining AI with genetic and lifestyle insights, GeneLink empowers marketers with unmatched precision, while giving individuals real value, trust, and rewards by sharing their data.”
GeneLink embeds privacy by design, ensuring all interactions are consent-driven, data-encrypted, anonymized, and compliant with global regulations. This commitment builds user confidence, encouraging voluntary data sharing that fuels the platform's insights. Participants benefit from the GeneLife Points system, where sharing genetic and lifestyle information earns redeemable credits for wellness products and services via the GeneLife app. Future expansions will integrate with broader loyalty programs, enhancing accessibility. GeneLife, A.D.A.M. Innovations' consumer brand, holds a dominant 74% market share in Japan's direct-to-consumer genetic testing, underscoring its credibility in personalized health solutions.
Beyond monetizing engagement, GeneLink reorients advertising toward societal good, promoting healthier lifestyles through prevention-focused content. This model creates a virtuous cycle where users receive actionable wellness guidance, brands achieve higher conversion rates, and the platform contributes to public health advancements. Initial rollout focuses on Japan, capitalizing on the company's deep-rooted genomic expertise, with international growth planned to extend this ecosystem globally. For more details, visit www.adam-innovations.com/genelink.
Note: Genesis Healthcare Co. is to be renamed A.D.A.M. Innovations Co. effective Nov. 1, 2025.
GeneLink's launch heralds a future where advertising aligns with personal biology and well-being, setting a new benchmark for ethical, effective precision marketing that benefits individuals, brands, and communities alike.
Founded in 2004 in Tokyo, A.D.A.M. Innovations is a pioneer in genomics, AI, and precision health solutions. The company develops cutting-edge technologies spanning consumer genetics, clinical diagnostics, and AI-driven R&D data platforms. To date, A.D.A.M. Innovations has conducted more than 2.8 million genetic tests and maintains the largest R&D genomic database of the Japanese population.
GeneLife is the consumer brand of A.D.A.M. Innovations. GeneLife, brings genetic testing directly to individuals through at-home kits and e-commerce channels. With a 74% market share (source: Fuji Kimera), GeneLife stands as the market leader, delivering personalized health and wellness insights to empower better living and longevity. GeneLife rewards its users with GeneLife Points through its mobile application, offering incentives for participating in R&D programs, engaging in promotional activities, and contributing to the advancement of personalized health and wellness.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.